Prospective Study of Primary Pterygium Surgery using Pterygium Extended Removal Followed by Extended Conjunctival Transplantation

Ophthalmology

Volumn 115, Issue 10, 2008, Pages 1663-1672

  Hirst, Lawrence W ^a  

^a QUEENSLAND EYE INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOGRAFT; CONTROLLED STUDY; EYE SURGERY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PTERYGIUM; SURGEON;

CONJUNCTIVA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OPHTHALMOLOGIC SURGICAL PROCEDURES; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PTERYGIUM; RECURRENCE; TRANSPLANTATION, AUTOLOGOUS;

EID: 52949113422     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2008.03.012     Document Type: Article

References (62)

1. Hirst L.W. The treatment of pterygium. Surv Ophthalmol 48 (2003) 145-180
2. Jurgenliemk-Schulz I.M., Hartman L.J., Roesink J.M., et al. Prevention of pterygium recurrence by postoperative single-dose beta-irradiation: a prospective randomized clinical double-blind trial. Int J Radiat Oncol Biol Phys 59 (2004) 1138-1147
3. Prabhasawat P., Barton K., Burkett G., and Tseng S.C. Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmology 104 (1997) 974-985
4. Kilic A., and Gurler B. The efficiency of limbal conjunctival autografting in pterygium surgery. Eur J Ophthalmol 16 (2006) 365-370
5. Sanchez-Thorin J.C., Rocha G., and Yelin J.B. Meta-analysis on the recurrence rates after bare sclera resection with and without mitomycin C use and conjunctival autograft placement in surgery for primary pterygium. Br J Ophthalmol 82 (1998) 661-665
6. Tan D.T., Chee S.P., Dear K.B., and Lim A.S. Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol 115 (1997) 1235-1240
7. Fernandes M., Sangwan V.S., Bansal A.K., et al. Outcome of pterygium surgery: analysis over 14 years. Eye 19 (2005) 1182-1190
8. Yanyali A.C., Talu H., Alp B.N., et al. Intraoperative mitomycin C in the treatment of pterygium. Cornea 19 (2000) 471-473
9. Panda A., Das G.K., Tuli S.W., and Kumar A. Randomized trial of intraoperative mitomycin C in surgery for pterygium. Am J Ophthalmol 125 (1998) 59-63
10. Frucht-Pery J., Siganos C.S., and Ilsar M. Intraoperative application of topical mitomycin C for pterygium surgery. Ophthalmology 103 (1996) 674-677
11. Cardillo J.A., Alves M.R., Ambrosio L.E., et al. Single intraoperative application versus postoperative mitomycin C eye drops in pterygium surgery. Ophthalmology 102 (1995) 1949-1952
12. Sanchez-Thorin J.C. A randomized trial comparing mitomycin C and conjunctival autograft after excision of primary pterygium [letter]. Am J Ophthalmol 121 (1996) 333-334
13. Riordan-Eva P., Kielhorn I., Ficker L.A., et al. Conjunctival autografting in the surgical management of pterygium. Eye 7 (1993) 634-638
14. Ma D.H., See L.C., Liau S.B., and Tsai R.J. Amniotic membrane graft for primary pterygium: comparison with conjunctival autograft and topical mitomycin C treatment. Br J Ophthalmol 84 (2000) 973-978
15. Simsek T., Gunalp I., and Atilla H. Comparative efficacy of beta-irradiation and mitomycin-C in primary and recurrent pterygium. Eur J Ophthalmol 11 (2001) 126-132
16. Young A.L., Leung G.Y., Wong A.K., et al. A randomised trial comparing 0.02% mitomycin C and limbal conjunctival autograft after excision of primary pterygium. Br J Ophthalmol 88 (2004) 995-997
17. Manning C.A., Kloess P.M., Diaz M.D., and Yee R.W. Intraoperative mitomycin in primary pterygium excision: a prospective, randomized trial. Ophthalmology 104 (1997) 844-848
18. Oguz H., Basar E., and Gurler B. Intraoperative application versus postoperative mitomycin C eye drops in pterygium surgery. Acta Ophthalmol Scand 77 (1999) 147-150
19. Amano S., Motoyama Y., Oshika T., et al. Comparative study of intraoperative mitomycin C and beta irradiation in pterygium surgery. Br J Ophthalmol 84 (2000) 618-621
20. Lam D.S., Wong A.K., Fan D.S., et al. Intraoperative mitomycin C to prevent recurrence of pterygium after excision: a 30-month follow-up study. Ophthalmology 105 (1998) 901-904
21. Isohashi F., Inoue T., Xing S., et al. Postoperative irradiation for pterygium: retrospective analysis of 1,253 patients from the Osaka University Hospital. Strahlenther Onkol 182 (2006) 437-442
22. Nishimura Y., Nakai A., Yoshimasu T., et al. Long-term results of fractionated strontium-90 radiation therapy for pterygia. Int J Radiat Oncol Biol Phys 46 (2000) 137-141
23. Wilder R.B., Buatti J.M., Kittelson J.M., et al. Pterygium treated with excision and postoperative beta irradiation. Int J Radiat Oncol Biol Phys 23 (1992) 533-537
24. MacKenzie F.D., Hirst L.W., Kynaston B., and Bain C. Recurrence rate and complications after beta irradiation for pterygia. Ophthalmology 98 (1991) 1776-1780
25. Luanratanakorn P., Ratanapakorn T., Suwan-Apichon O., and Chuck R.S. Randomised controlled study of conjunctival autograft versus amniotic membrane graft in pterygium excision. Br J Ophthalmol 90 (2006) 1476-1480
26. Essex R.W., Snibson G.R., Daniell M., and Tole D.M. Amniotic membrane grafting in the surgical management of primary pterygium. Clin Experiment Ophthalmol 32 (2004) 501-504
27. Tananuvat N., and Martin T. The results of amniotic membrane transplantation for primary pterygium compared with conjunctival autograft. Cornea 23 (2004) 458-463
28. Solomon A., Pires R.T., and Tseng S.C. Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia. Ophthalmology 108 (2001) 449-460
29. Kenyon K.R., Wagoner M.D., and Hettinger M.E. Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology 92 (1985) 1461-1470
30. Mejia L.F., Sanchez J.G., and Escobar H. Management of primary pterygia using free conjunctival and limbal-conjunctival autografts without antimetabolites. Cornea 24 (2005) 972-975
31. Allan B.D., Short P., Crawford G.J., et al. Pterygium excision with conjunctival autografting: an effective and safe technique. Br J Ophthalmol 77 (1993) 698-701
32. Hirst L.W., Sebban A., and Chant D. Pterygium recurrence time. Ophthalmology 101 (1994) 755-758
33. Hirschberg J. The History of Ophthalmology. Vol 1. Antiquity. Blodi FC, trans. (1982), Wayenborgh, Bonn, Germany 47, 57, 87, 190, 199, 203, 239, 288, 345
34. Hirschberg J. The History of Ophthalmology. Vol 2. The Middle Ages. The Sixteenth and Seventeenth Centuries. Blodi FC, trans. (1985), Wayenborgh, Bonn, Germany 69, 136, 138, 201, 333, 334
35. Tarr K.H., and Constable I.J. Late complications of pterygium treatment. Br J Ophthalmol 64 (1980) 496-505
36. Tarr K.H., and Constable I.J. Pseudomonas endophthalmitis associated with scleral necrosis. Br J Ophthalmol 64 (1980) 676-679
37. Barron A., McDonald J.E., and Hughes W.F. Long-term complications of beta-radiation therapy in ophthalmology. Trans Am Ophthalmol Soc 68 (1970) 113-128
38. Cameron M.E. Preventable complications of pterygium excision with beta-irradiation. Br J Ophthalmol 56 (1972) 52-56
39. Haik G.M., Lyda W., Waugh Jr. R.L., and Ellis G. Cataract formation following beta-ray radium therapy. Am J Ophthalmol 38 (1954) 465-470
40. Linnér E., and Rosengren B. Complications following eye treatment with 90Sr applicator. Acta Ophthalmol (Copenh) 47 (1969) 202-207
41. Talbot A.N. Complications of beta ray treatment of pterygia. Trans Ophthalmol Soc N Z 31 (1979) 62-63
42. Dougherty P.J., Hardten D.R., and Lindstrom R.L. Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin-C. Cornea 15 (1996) 537-540
43. Dunn J.P., Seamone C.D., Ostler H.B., et al. Development of scleral ulceration and calcification after pterygium excision and mitomycin therapy [letter]. Am J Ophthalmol 112 (1991) 343-344
44. Ewing-Chow D.A., Romanchuk K.G., Gilmour G.R., et al. Corneal melting after pterygium removal followed by topical mitomycin C therapy. Can J Ophthalmol 27 (1992) 197-199
45. Fujitani A., Hayasaka S., Shibuya Y., and Noda S. Corneoscleral ulceration and corneal perforation after pterygium excision and topical mitomycin C therapy. Ophthalmologica 207 (1993) 162-164
46. Fukamachi Y., and Hikita N. Ocular complication following pterygium operation and instillation of mitomycin C. Nippon Ganka Kiyo 32 (1981) 197-201
47. Rubinfeld R.S., Pfister R.R., Stein R.M., et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology 99 (1992) 1647-1654
48. Yamanouchi U., Takaku I., and Tsuda N. Scleromalacia presumably due to mitomycin C instillation after pterygium excision. Rinsho Ganka 33 (1979) 139-144
49. Yamanouchi U. A case of scleral calcification due to mitomycin C instillation after pterygium operation. Nippon Ganka Kiyo 29 (1978) 1221-1225
50. Barraquer J.I. Etiology, pathogenesis, and treatment of the pterygium. Trans New Orleans Acad Ophthalmol (1980) 167-178
51. Starck T., Kenyon K.R., and Serrano F. Conjunctival autograft for primary and recurrent pterygia: surgical technique and problem management. Cornea 10 (1991) 196-202
52. Syam P.P., Eleftheriadis H., and Liu C.S. Inferior conjunctival autograft for primary pterygia. Ophthalmology 110 (2003) 806-810
53. Massaoutis P., Khemka S., and Ayliffe W. Clinical outcome study of a modified surgical technique for pterygium excision. Can J Ophthalmol 41 (2006) 704-708
54. Hirst L.W. Treatment of pterygium. Aust N Z J Ophthalmol 26 (1998) 269-270
55. Sebban A., and Hirst L.W. Pterygium recurrence rate at the Princess Alexandra Hospital. Aust N Z J Ophthalmol 19 (1991) 203-206
56. Sebban A., and Hirst L.W. Treatment of pterygia in Queensland. Aust N Z J Ophthalmol 19 (1991) 123-127
57. Troutbeck R., and Hirst L. Review of treatment of pterygium in Queensland: 10 years after a primary survey. Clin Experiment Ophthalmol 29 (2001) 286-290
58. Kria L., Ohira A., and Amemiya T. Growth factors in cultured pterygium fibroblasts: immunohistochemical and ELISA analysis. Graefes Arch Clin Exp Ophthalmol 236 (1998) 702-708
59. Kria L., Ohira A., and Amemiya T. TNP-470 (a fungus-derived inhibitor of angiogenesis) reduces proliferation of cultured fibroblasts isolated from primary pterygia: a possible drug therapy for pterygia. Curr Eye Res 17 (1998) 986-993
60. Denk P.O., Hoppe J., Hoppe V., and Knorr M. Effect of growth factors on the activation of human Tenon's capsule fibroblasts. Curr Eye Res 27 (2003) 35-44
61. Denk P.O., Roth-Eichhorn S., Gressner A.M., and Knorr M. Cytokine regulation of hyaluronate production by human Tenon's capsule fibroblasts. Curr Eye Res 20 (2000) 77-80
62. Gris O., Guell J.L., and del Campo Z. Limbal-conjunctival autograft transplantation for the treatment of recurrent pterygium. Ophthalmology 107 (2000) 270-273